Research Areas

Explore strategies for characterizing CAR T cells across development, manufacturing, and functional testing to support robust cell therapy research.

The new service adds metabolite profiling to Novogene Europe's genomics and transcriptomics capabilities, supporting integrated multiomics research.

High-throughput screening has always been about speed and volume. As assays grow more biologically complex, the harder question is whether the data they generate can actually be trusted at scale.

Data on a new oral pill for Duchenne muscular dystrophy, a miss for a heart drug, a $10B acquisition of Crinetics, and more led the news this week.

Researchers showed that an oral medication can activate worn-out T cells.

7-methylxanthine is being reformulated into a sustained-release oral therapy aimed at improving long-term control of axial elongation in childhood myopia.

As soaring costs and logistical complexity strain traditional cell therapy models, in vivo CAR T is prompting a fundamental rethink of how advanced therapies are manufactured and scaled.

Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.

Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.

The Synthetic Molecule Process Innovation Phorum brings together major pharma companies, regulators, and CDMOs to build consensus on pressing challenges in small molecule manufacturing.